FDA Inspection 988104 — Eurofins BioPharma Product Testing Czech Republic s.r.o.
The FDA completed an inspection of Eurofins BioPharma Product Testing Czech Republic s.r.o. on August 9, 2016 in Brno-Jih. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 9, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Brno-Jih (Czech Republic)